DOTA (chelator)
DOTA (also known as tetraxetan) is an organic compound with the formula (CH2CH2NCH2CO2H)4. The molecule consists of a central 12-membered tetraaza (i.e., containing four nitrogen atoms) ring. DOTA is used as a complexing agent, especially for lanthanide ions. Its complexes have medical applications as contrast agents and cancer treatments.
Wikipage disambiguates
1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetate90Y-DOTA-biotinActiniumAminopolycarboxylic acidC16H28N4O8Copper-64DOTA-TATEDOTA (Chelate)DOTA (chelate)DenticityDota (disambiguation)Edotreotide1,2-dimethoxyethaanGadoteric acidGallium scanLanthanideLigandLilotomabList of drugs: TeMetal-coded affinity tagPeptide receptor radionuclide therapyRadioactivity in the life sciencesRadionuclide therapyScandium-44TetraxetanYttrium (90Y) clivatuzumab tetraxetanYttrium (90Y) tacatuzumab tetraxetan
Link from a Wikipage to another Wikipage
primaryTopic
DOTA (chelator)
DOTA (also known as tetraxetan) is an organic compound with the formula (CH2CH2NCH2CO2H)4. The molecule consists of a central 12-membered tetraaza (i.e., containing four nitrogen atoms) ring. DOTA is used as a complexing agent, especially for lanthanide ions. Its complexes have medical applications as contrast agents and cancer treatments.
has abstract
1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸（ ...... 衍生物可用作双功能螯合剂，这两种新物质于1988年首次报道。
@zh
DOTA (also known as tetraxetan ...... agents and cancer treatments.
@en
DOTA（1,4,7,10-テトラアザシクロドデカン-1,4 ...... いられ、その錯体は造影剤、癌治療などの医療に応用されている。
@ja
alternative name
DotA; Tetraxetan
@en
IUPAC name
2,2′,2′′,2′′′-(1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetrayl)tetraacetic acid
@en
Wikipage page ID
22,447,230
page length (characters) of wiki page
Wikipage revision ID
1,017,063,732
Link from a Wikipage to another Wikipage
ImageFile
@en
ImageName
DOTA
@en
name
DOTA
@en
OtherNames
DotA; Tetraxetan
@en
Verifiedfields
changed
@en
verifiedrevid
458,276,313
Watchedfields
changed
@en
wikiPageUsesTemplate
subject
hypernym
comment
1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸（ ...... 衍生物可用作双功能螯合剂，这两种新物质于1988年首次报道。
@zh
DOTA (also known as tetraxetan ...... agents and cancer treatments.
@en
DOTA（1,4,7,10-テトラアザシクロドデカン-1,4 ...... いられ、その錯体は造影剤、癌治療などの医療に応用されている。
@ja
label
1,4,7,10-Tetraazacyclododecan-1,4,7,10-tetraessigsäure
@de
DOTA (chelator)
@en
DOTA (キレート剤)
@ja
DOTA (螯合剂)
@zh
sameAs
wasDerivedFrom
isPrimaryTopicOf
name
DOTA
@en